Memory, language, and praxis in Alzheimer's disease: Norms for outpatient clinical trial populations

Psychopharmacology Bulletin

Volumn 33, Issue 1, 1997, Pages 123-128

  Doraiswamy, P M ^b   Bieber, F ^a,c   Kaiser, L ^a   Connors, K ^b   Krishnan, K R ^b   Reuning Scherer, J ^a,d   Gulanski, B ^a  

^a BAYER CORPORATION   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BAYER AG   (Germany)

^d YALE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; clinical trials; language; memory; neuropsychological tests; praxis

Indexed keywords

ANTIINFLAMMATORY AGENT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISCRIMINANT ANALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LANGUAGE ABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

AGED; ALZHEIMER DISEASE; CLINICAL TRIALS; COGNITION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LANGUAGE; MALE; MEMORY; OUTPATIENTS; REFERENCE STANDARDS;

EID: 0030983743     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: American Psychiatric Association, 1987.
2. Davis, KL; Thal, U; Gamzu, ER; Davis, CS; Woolson, RF; Gracon, SI; Drachman, DA; Schneider, LS; Whitehouse, PF; Hoover, TM; Morris, JC; Kawas, CH; Knopman, DS; Earl, NL; Kumar, V; Doody RS and the Tacrine Collaborative Study Group. A double-blind multicenter study of tacrine for Alzheimer's disease. N. Engl. J. Med. 327:1253-1259, 1992.
3. Doraiswamy, PM; Bieber, F; Kaiser, L; Krishnan, KR; Reuning-Scherer, J; and Gulanski, B. The Alzheimer's Disease Assessment Scale: Patterns and predictors of baseline cognitive performance. Neurology, in press, 1996a.
4. Doraiswamy, PM; Krishen, A; Stallone, F; Martin, W; Metz, A; and DeVeaugh-Geiss, J. NSAID use and cognition in Alzheimer's disease (Letter). Neurology 46:1194, 1996b.
5. Folstein, MF; Folstein, SE; and McHugh, PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198, 1975.
6. Hachinski, V; Linnette, D; Zilhka, E; Boulay, G; McAllister, V; Marshall, J; Russell, R; and Symon, L. Cerebral blood flow in dementia. Arch. Neurol. 32:632-637, 1975.
7. Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56-62, 1960.
8. Kim, YS; Nibbelink, DW; and Overall, JE. Factor structure and reliability of the ADAS in a multicenter trial with linopiridine. J. Geriatr. Psychiatry Neurol. 7:74-83, 1994.
9. Reisberg, B; Ferris, S; De Leon, MJ; and Crook, T. The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139:1136-1139, 1982.
10. Rosen, WG; Mohs, RC; and Davis, KL. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141(11):1356-1364, 1984.
11. Rosen, WG; Terry, RD; and Fuld, PA. Pathological verification of ischemic score in differentiation of dementias. Ann. Neurol. 7:486-488, 1979.
12. Stern, RG; Mohs, RC; Davidson, M; Schmeidler, J; Silverman, J; Kramer-Ginsberg, E; Searcey, T; Bierer, L; and Davis, KL. A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration. Am. J. Psychiatry 151:390-396, 1994.
13. Talwalker, S; Overall, JE; Srirama, M; and Gracon, S. Cardinal features of cognitive dysfunction in Alzheimer's disease: A factor analytic study of the Alzheimer's Disease Assessment Scale. J. Geriatr. Psychiatry Neurol. 9:39-46, 1996.
14. Zee, RF; Landreth, ES; Vicari, SK; Belman, J; Feldman, E; Andrise, A; Robbs, R; Becker, R; and Kumar, V. Alzheimer's Disease Assessment Scale: A subtest analysis. Alzheimer Dis. Assoc. Disord. 6(3):164-181, 1992.